Oakbrook Investments LLC raised its holdings in Equifax Inc. (NYSE:EFX) by 41.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,627 shares of the credit services provider’s stock after acquiring an additional 4,000 shares during the quarter. Oakbrook Investments LLC’s holdings in Equifax were worth $1,779,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Qube Research & Technologies Ltd lifted its stake in shares of Equifax by 1,375.6% in the second quarter. Qube Research & Technologies Ltd now owns 1,151 shares of the credit services provider’s stock worth $144,000 after buying an additional 1,073 shares during the last quarter. Valeo Financial Advisors LLC acquired a new stake in shares of Equifax in the second quarter worth $158,000. Piedmont Investment Advisors LLC acquired a new stake in shares of Equifax in the second quarter worth $175,000. Deroy & Devereaux Private Investment Counsel Inc. acquired a new stake in shares of Equifax in the second quarter worth $200,000. Finally, FineMark National Bank & Trust acquired a new stake in shares of Equifax in the second quarter worth $200,000. Hedge funds and other institutional investors own 92.26% of the company’s stock.
A number of analysts have recently weighed in on the stock. Morgan Stanley restated a “hold” rating and issued a $127.00 price objective on shares of Equifax in a research note on Thursday, September 13th. ValuEngine raised shares of Equifax from a “hold” rating to a “buy” rating in a research report on Tuesday, September 11th. Wells Fargo & Co boosted their target price on shares of Equifax from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, October 1st. Zacks Investment Research raised shares of Equifax from a “sell” rating to a “hold” rating in a research report on Friday, July 20th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Equifax from $135.00 to $150.00 and gave the stock an “overweight” rating in a research report on Friday, July 27th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $129.30.
Equifax (NYSE:EFX) last announced its earnings results on Wednesday, July 25th. The credit services provider reported $1.56 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.54 by $0.02. Equifax had a net margin of 14.76% and a return on equity of 22.03%. The business had revenue of $876.90 million for the quarter, compared to analyst estimates of $886.00 million. During the same quarter in the previous year, the firm posted $1.60 earnings per share. Equifax’s revenue was up 2.4% compared to the same quarter last year. Analysts predict that Equifax Inc. will post 5.85 EPS for the current year.
Equifax Inc provides information solutions and human resources business process outsourcing services for businesses, governments, and consumers. The company operates through four segments: U.S. Information Solutions (USIS), International, Workforce Solutions, and Global Consumer Solutions. The USIS segment offers consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting; mortgage loan origination information; financial marketing; and identity management services.
Read More: What is a closed-end mutual fund (CEF)?
Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax Inc. (NYSE:EFX).
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.